Screener
GeneDx Holdings WGS Gross Carrying Amount
Gross Carrying Amount at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | Gross Carrying Amount | Accumulated Amortization | Accumulated Impairment | Net Carrying Value | Weighted-Average Amortization Period (Years) |
|---|---|---|---|---|---|
| Tradenames and trademarks | $54,500 | $(12,514) | $(4,225) | $37,761 | 12.1 |
| Developed technology | 62,900 | (25,018) | (10,182) | 27,700 | 4.5 |
| Customer relationships | 104,100 | (19,591) | (5,001) | 79,508 | 16.1 |
| $221,500 | $(57,123) | $(19,408) | $144,969 | 12.8 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's gross carrying amount?
- GeneDx Holdings (WGS) reported gross carrying amount of $221.5M in Q1 2026.
- How has GeneDx Holdings's gross carrying amount changed year-over-year?
- GeneDx Holdings's gross carrying amount increased by 13.0% year-over-year, from $196M to $221.5M.
Ask your AI about GeneDx Holdings's gross carrying amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude